Butenafine/betamethasone dipropionate

Drug Profile

Butenafine/betamethasone dipropionate

Alternative Names: 501 cream

Latest Information Update: 20 Nov 2003

Price : $50

At a glance

  • Originator Bertek Pharmaceuticals
  • Class Anti-inflammatories; Antifungals; Fluorinated steroids; Glucocorticoids
  • Mechanism of Action Immunosuppressants; Squalene monooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Tinea pedis

Most Recent Events

  • 20 Nov 2003 Discontinued - Phase-III for Tinea pedis in USA (Topical)
  • 13 Nov 1997 Phase-III clinical trials for Tinea pedis in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top